Sareum - sareum.co.uk
General Information:
Latest News:
Trading Statement 12 Aug 2013 | 12:02 pm
(AIM: SAR) 12 Aug 2013 SAREUM HOLDINGS PLC (“Sareum” or “the Company”) Pre-Close Trading Statement Sareum, the specialist cancer drug discovery business, is pleased to provide the following pre-c...
Selection for Preclinical Candidate 15 Jul 2013 | 12:01 pm
Normal 0 false false false EN-GB X-NONE X-NONE (AIM: SAR) 15 July 2013 SAREUM HOLDINGS PLC (“Sareum”) Preclinical Development Candidate Selected for Aurora+FLT3 Inhibitor Programme Sareum...
Total Voting Rights 10 May 2013 | 05:00 pm
800x600 (AIM : SAR) 10 May 2013 Sareum Holdings plc (“Sareum” or “the Company”) Total Voting Rights The Company announces that, pursuant to the requirements of the Disclosure and Transparency Ru...
Sareum Notified of Grant Award 24 Apr 2013 | 12:00 pm
Normal 0 false false false EN-GB X-NONE X-NONE 24 April 2013 SAREUM HOLDINGS PLC (“Sareum” or “the Company”) SAREUM NOTIFIED OF GRANT AWARD FROM UK TECHNOLOGY STRATEGY BOARD Award worth up...
Sareum and SRI International Announce Co-development Agreement 22 Apr 2013 | 12:00 pm
SAREUM HOLDINGS PLC and SRI INTERNATIONAL (“SAREUM” and “SRI”) SAREUM and SRI INTERNATIONAL ANNOUNCE AGREEMENT to ADVANCE DEVELOPMENT of TYROSINE KINASE 2 INHIBITORS for TREATMENT of AUTOIMMUNE and ...
Issue of Equity 25 Mar 2013 | 11:02 am
(AIM: SAR) 25 March 2013 SAREUM HOLDINGS PLC (“Sareum” or “the Company”) Issue of Equity Sareum, the specialist cancer drug discovery business, announces the Company has drawn down £350,000 again...
Adviser Change of Name 19 Mar 2013 | 11:01 am
800x600 19 March 2013 Sareum Holdings plc (the “Company”) Adviser Change of Name The Company announces that its Nominated Adviser, Merchant Securities Limited, has changed its name to Sanlam Secu...
Research Update 18 Feb 2013 | 12:02 pm
Normal 0 false false false EN-GB X-NONE X-NONE (AIM: SAR) 18 February 2013 SAREUM HOLDINGS PLC (“Sareum” or the “Company”) Research Update: Research Programmes Continue To Show Positive Pr...
Half-Yearly Report 18 Feb 2013 | 12:01 pm
800x600 18 February 2013 SAREUM HOLDINGS PLC (“Sareum” or “the Company”) HALF-YEARLY RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2012 Sareum (AIM: SAR), the specialist cancer drug discovery busi...
Director Declaration 11 Feb 2013 | 05:00 am
11 February 2013 Sareum Holdings plc ("Sareum" or "the Company") Director Declaration Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery business, notes the announcement of Angel...
